INTRODUCTION AND HYPOTHESIS: The Self-Assessment Goal Achievement (SAGA) questionnaire was developed to identify treatment goals and assess goal-achievement in patients with lower urinary tract symptoms (LUTS). METHODS: This study consisted of (1) gathering information on goal setting/attainment concepts, (2) goal elicitation (n = 41 patients with LUTS), (3) cognitive debriefing of draft questionnaire (n = 11), and (4) pilot testing (n = 104). RESULTS: SAGA consists of baseline (goal-assessment; ranking) and follow-up (goal-achievement) modules. In addition to goals most frequently mentioned, patients can list up to five open goals. Goals most commonly reported as "very important" in pilot testing included reducing urgency (72%), incontinence (65%), and nocturia (64%). Treatment goals spontaneously reported as "very important" were reducing incontinence (45%), nocturia (40%), and frequency (26%). CONCLUSIONS: SAGA may be used to identify treatment goals and assess goal-achievement in patients with LUTS in the clinic and for research (with additional validation). This information may promote patient-physician interaction and help patients establish realistic treatment goals, which may in turn improve treatment adherence and outcomes.
INTRODUCTION AND HYPOTHESIS: The Self-Assessment Goal Achievement (SAGA) questionnaire was developed to identify treatment goals and assess goal-achievement in patients with lower urinary tract symptoms (LUTS). METHODS: This study consisted of (1) gathering information on goal setting/attainment concepts, (2) goal elicitation (n = 41 patients with LUTS), (3) cognitive debriefing of draft questionnaire (n = 11), and (4) pilot testing (n = 104). RESULTS: SAGA consists of baseline (goal-assessment; ranking) and follow-up (goal-achievement) modules. In addition to goals most frequently mentioned, patients can list up to five open goals. Goals most commonly reported as "very important" in pilot testing included reducing urgency (72%), incontinence (65%), and nocturia (64%). Treatment goals spontaneously reported as "very important" were reducing incontinence (45%), nocturia (40%), and frequency (26%). CONCLUSIONS: SAGA may be used to identify treatment goals and assess goal-achievement in patients with LUTS in the clinic and for research (with additional validation). This information may promote patient-physician interaction and help patients establish realistic treatment goals, which may in turn improve treatment adherence and outcomes.
Authors: Eman A Elkadry; Kimberly S Kenton; Mary P FitzGerald; Susan Shott; Linda Brubaker Journal: Am J Obstet Gynecol Date: 2003-12 Impact factor: 8.661
Authors: Sangeeta T Mahajan; Eman A Elkadry; Kimberly S Kenton; Susan Shott; Linda Brubaker Journal: Am J Obstet Gynecol Date: 2006-03 Impact factor: 8.661
Authors: Joshua S Benner; Michael B Nichol; Eric S Rovner; Zhanna Jumadilova; Jose Alvir; Mohamed Hussein; Kristina Fanning; Jeffrey N Trocio; Linda Brubaker Journal: BJU Int Date: 2009-11-12 Impact factor: 5.588
Authors: Todd C Edwards; Rob J Fredericksen; Heidi M Crane; Paul K Crane; Mari M Kitahata; William C Mathews; Kenneth H Mayer; Leo S Morales; Michael J Mugavero; Rosa Solorio; Frances M Yang; Donald L Patrick Journal: Qual Life Res Date: 2015-08-06 Impact factor: 4.147
Authors: Vik Khullar; Daniela Marschall-Kehrel; Montserrat Espuna-Pons; Con J Kelleher; Shannon E Tully; Elisabeth C Piault; Linda Brubaker; Aino Fianu-Jonasson; David Weinstein; Agneta Bergqvist; Marion Kvasz Journal: Int Urogynecol J Date: 2013-04-09 Impact factor: 2.894
Authors: Elisabeth Piault; Sameepa Doshi; Barbara A Brandt; Çolpan Angün; Christopher J Evans; Agneta Bergqvist; Jeffrey Trocio Journal: Health Qual Life Outcomes Date: 2012-04-23 Impact factor: 3.186